In summary, serum PGRN level may be a useful biomarker in the differential diagnosis of IPF and non-IPF ILDs, especially in cases where a clear decision cannot be made due to an uncertain HRCT pattern and sufficient clinical information or histological confirmation is not available. The gene discussed is GRN; the disease is idiopathic pulmonary fibrosis.